IP Library Granted Patent US 7,531,325
Granted Patent B2
US 7,531,325 · App. 10/322,746 · Granted May 12, 2009

Method for cleavage of fusion proteins

Assignee: SemBioSys Genetics Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,325
App. No.
10/322,746
Granted
May 12, 2009
Kind
B2
Abstract

An improved method for recovering recombinantly produced polypeptides is described. The method involves expressing the recombinant polypeptide as a fusion protein with a pro-peptide. The pro-peptide-polypeptide fusion protein can be cleaved and the recombinant polypeptide released under the appropriate conditions.

Claims (33)

1. A method for the preparation of a recombinant polypeptide, comprising

a) transforming a non-human host cell an expression vector comprising:

(1) a nucleic acid sequence capable of regulating transcription in a host cell, operatively linked to

(2) a chimeric nucleic acid sequence encoding a fusion protein, wherein said chimeric nucleic acid sequence comprises (a) a nucleic acid sequence encoding a pro-peptide sequence comprising SEQ ID NO:10, linked in reading frame to (b) a nucleic acid sequence that is heterologous to the pro-peptide and that encodes the recombinant polypeptide, wherein the heterologous nucleic acid sequence is located immediately downstream of the nucleic acid sequence encoding the pro-peptide; operatively linked to

(3) a nucleic acid sequence encoding a termination region functional in said host cell,

b) growing the host cell to produce said fusion protein;

c) obtaining said fusion protein from said non-human host cell, and

d) contacting said fusion protein with a mature form of an autocatalytically maturing aspartic protease that cleaves the pro-peptide, whereby said pro-peptide is cleaved from said fusion protein to release said recombinant polypeptide.

2. A method according to claim 1 wherein said pro-peptide sequence comprises a sequence selected from the group consisting of SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9.

3. A method according to claim 1 wherein the recombinant polypeptide is selected from the group consisting of hirudin, carp growth hormone and cystatin.

4. A method according to claim 1 wherein step d) is effected under in vitro conditions.

5. A method according to claim 1 wherein step d) is effected under in vivo conditions.

6. A method according to claim 5 wherein step d) is effected in a tissue, organ, or bodily fluid of an animal.

7. A method according to claim 5 wherein step d) is effected in the milk, blood, the stomach, the gut or the kidneys of said animal.

8. A method according to claim 1 wherein said autocatalytically maturing aspartic protease is chymosin.

9. The method according to claim 8 wherein step d) is effected under in vitro conditions.

10. The method according to claim 8 wherein step d) is effected under in vivo conditions.

11. The method according to claim 10 wherein step d) is effected in a tissue, organ, or bodily fluid of an animal.

12. The method according to claim 11 wherein the tissue, organ, or bodily fluid is a stomach, kidney, gut, blood or milk of said animal.

13. A method according to claim 1 wherein said nucleic acid sequences are deoxyribonucleic acid (DNA) sequences.

14. The method according to claim 1 wherein step d) is effected at a pH of from about 2 to about 4.5.

15. A method for the preparation of a recombinant polypeptide, comprising

a) transforming a host cell with an expression vector comprising:

(1) a nucleic acid sequence capable of regulating transcription in a host cell, operatively linked to

(2) a chimeric nucleic acid sequence that encodes a fusion protein, wherein said chimeric nucleic acid sequence comprises (a) a nucleic acid sequence encoding a pro-peptide sequence comprising SEQ ID NO:10, linked in reading frame to (b) a nucleic acid sequence that is heterologous to the pro-peptide and that encodes the recombinant polypeptide wherein the heterologous nucleic acid sequence is located immediately downstream of the nucleic acid sequence encoding the pro-peptide; operatively linked to

(3) a nucleic acid sequence encoding a termination region that is functional in said host cell,

wherein the host cell is selected from the group consisting of bacterial cells, yeast cells and plant cells,

b) growing the host cell to produce said fusion protein;

c) contacting said fusion protein in vivo with a mature from of an autocatalytically maturing aspartic protease that cleaves the pro-peptide by expressing said autocatalytically maturing aspartic protease in said host cell,

whereby said pro-peptide is cleaved from said fusion protein to release recombinant polypeptide.

16. The method according to claim 15 , wherein said autocatalytically maturing aspartic protease is chymosin.

17. The method according to claim 15 wherein said autocatalytically maturing aspartic protease is pepsin.

18. The method according to claim 1 wherein said autocatalytically maturing aspartic protease is pepsin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2003
From: VAN ROOIJEN, GIJS; ALCANTARA, JOENEL; MOLONEY, MAURICE
To: SEMBIOSYS GENETICS INC.
Reel/Frame 014110/0758 →
Continuity (3)
Continuation In Part 0940248800
Provisional Application 6004425400 · Apr 25, 1997
Related Publication 20030166162A1 · Sep 4, 2003